Перегляд за автором "Murovska, M."

Результати 1-3 з 3

Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels

Rivkina, A.; Vitols, G.; Murovska, M.; Lejniece, S. (Experimental Oncology, 2011)

Serum thymidine kinase (TK), zeta-associated protein of 70 kDa (ZAP-70) and CD38 levels have been shown to be correlated with survival in chronic lymphocytic leukaemia (CLL). Aim: To investigate the possible correlations ...
Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia

Rivkina, A.; Kholodyuk I. Holodnuka; Murovska, M.; Soloveichika, M.; Lejniece, S. (Experimental Oncology, 2015)

Background: Up to now, the immune status of chronic lymphocytic leukemia (CLL) patients in association with the expression of zeta-chain-associated protein kinase 70 (ZAP-70) in leukemic cells has not been evaluated. Aim: ...
Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient

Lejniece, S.; Murovska, M.; Chapenko, S.; Breiksa, B.; Jaunmuktane, Z.; Feldmane, L.; Ziedlina, I.; Gomez-Roman, J.; Garcia-Cabeza, M.; Lejnieks, A. (Experimental Oncology, 2011)

Progressive multifocal leukoencephalopathy (PML) is a neurological disease caused by infection of the central nervous system (CNS) with the JC polyomavirus (JCV). JCV is endemic and infects a large proportion (70–90%) of ...

Результати 1-3 з 3

Пошук